Maternal or infant antiretroviral drugs to reduce HIV-1 transmission

New England Journal of Medicine

Volumn 362, Issue 24, 2010, Pages 2271-2281

  Chasela, Charles S ^a   Hudgens, Michael G ^b   Jamieson, Denise J ^d   Kayira, Dumbani ^a   Hosseinipour, Mina C ^a,b   Kourtis, Athena P ^d   Martinson, Francis ^a   Tegha, Gerald ^a   Knight, Rodney J ^c   Ahmed, Yusuf I ^d   Kamwendo, Deborah D ^a,b   Hoffman, Irving F ^b   Ellington, Sascha R ^d   Kacheche, Zebrone ^a   Soko, Alice ^a   Wiener, Jeffrey B ^d   Fiscus, Susan A ^b   Kazembe, Peter ^b   Mofolo, Innocent A ^b   Chigwenembe, Maggie ^a   Sichali, Dorothy S ^a   Van Der Horst, Charles M ^b   more..

^a UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Principia   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; COTRIMOXAZOLE; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; ANTIRETROVIRUS AGENT; ZIDOVUDINE;

ADULT; ARTICLE; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EOSINOPHILIA; FEMALE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; MAJOR CLINICAL STUDY; MALAWI; MALE; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SINGLE DRUG DOSE; STEVENS JOHNSON SYNDROME; VERTICAL TRANSMISSION; CHEMICALLY INDUCED DISORDER; DISEASE TRANSMISSION; DRUG COMBINATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPLAN MEIER METHOD; MULTICENTER STUDY; NEWBORN; PREGNANCY; RISK FACTOR; SERODIAGNOSIS;

ADULT; ANTI-RETROVIRAL AGENTS; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; DRUG HYPERSENSITIVITY; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; KAPLAN-MEIERS ESTIMATE; LAMIVUDINE; MALE; NEUTROPENIA; NEVIRAPINE; PREGNANCY; RISK FACTORS; STEVENS-JOHNSON SYNDROME; YOUNG ADULT; ZIDOVUDINE;

EID: 77953723667     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0911486     Document Type: Article

References (27)

1. HIV transmission through breastfeeding: a review of available evidence. Geneva: World Health Organization, 2007.
2. AIDS epidemic update. Geneva: Joint United Nations Programme on HIV/AIDS, 2007.
3. Newell ML, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004;364:1236-43.
4. Thior I, Lockman S, Smeaton LM, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 2006;296:794-805.
5. WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality. Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. Lancet 2000;355:451-5.
6. HIV and infant feeding: revised principles and recommendations: rapid advice. Geneva: World Health Organization, 2009. (Accessed May 26, 2010, at http://www.who.int/child-adolescent-health/documents/9789241598873/en/index. html.)
7. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004;351:217-28.
8. Achievements in public health: reduction in perinatal transmission of HIV infection - United States, 1985-2005. MMWR Morb Mortal Wkly Rep 2006;55:592-7.
9. Coutsoudis A, Dabis F, Fawzi W, et al. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis 2004;189:2154-66.
10. Palombi L, Marazzi MC, Voetberg A, Magid NA. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. AIDS 2007;21:Suppl 4:S65-S71.
11. Shapiro RL, Hughes M, Ogwu A, et al. A randomized trial comparing highly active antiretroviral therapy regimens for virologic efficacy and the prevention of mother-to-child HIV transmission among breastfeeding women in Botswana (The Mma Bana Study). In: Proceedings of the International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention, Cape Town, South Africa, July 19-22, 2009:175. abstract.
12. Thomas T, Masaba R, Ndivo R, Zeh C, Borkowi C. Prevention of mother-to-child transmission of HIV-1 among breastfeeding mothers using HAART: the Kisumu breastfeeding study, Kisumu, Kenya, 2003-2007. In: Program and abstracts of the 15th Conference on Retroviruses and Opportunistic Infections, Boston, February 3-6, 2008:87. abstract.
13. Kilewo C, Karlsson K, Ngarina M, et al. Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study. J Acquir Immune Defic Syndr 2009;52:406-16.
14. Peltier CA, Ndayisaba GF, Lepage P, et al. Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda. AIDS 2009;23:2415-23.
15. Bedri A, Gudetta B, Isehak A, et al. Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 2008; 372:300-13.
16. Kumwenda NI, Hoover DR, Mofenson LM, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 2008;359:119-29.
17. van der Horst C, Chasela C, Ahmed Y, et al. Modifications of a large HIV prevention clinical trial to fit changing realities: a case study of the Breastfeeding, Antiretroviral, and Nutrition (BAN) protocol in Lilongwe, Malawi. Contemp Clin Trials 2009;30:24-33.
18. Moses A, Zimba C, Kamanga E, et al. Prevention of mother-to-child transmission: program changes and the effect on uptake of the HIVNET 012 regimen in Malawi. AIDS 2008;22:83-7. (Pubitemid 350294881)
19. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
20. Kourtis AP, Bramson B, van der Horst C, et al. Low absolute neutrophil counts in African infants. J Int Assoc Physicians AIDS Care (Chic Ill) 2005;4(3):73-6.
21. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics 1979;35:549-56.
22. Kafulafula G, Hoover DR, Taha TE, et al. Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-infected women in Malawi. J Acquir Immune Defic Syndr 2010;53:6-13.
23. Kuhn L, Aldrovandi GM, Sinkala M, et al. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med 2008;359:130-41.
24. Darwich L, Esteve A, Ruiz L, Bellido R, Clotet B, Martinez-Picado J. Variability in the plasma concentration of efavirenz and nevirapine is associated with genotypic resistance after treatment interruption. Antivir Ther 2008;13:945-51.
25. Hosseinipour MC, van Oosterhout JJ, Weigel R, et al. The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy. AIDS 2009;23:1127-34.
26. Zeh C, Weidle P, Nafisa L, Musuluma H, Okonji J, Anyango E. Emergence of HIV-1 drug resistance among breastfeeding infants born to HIV-infected mothers taking antiretrovirals for prevention of mother-to-child transmission of HIV: the Kisumu Breastfeeding Study, Kenya. In: Program and abstracts of the 15th Conference on Retroviruses and Opportunistic Infections, Boston, February 3-6, 2008: 102. abstract.
27. Lidstrom J, Guay L, Musoke P, et al. Multi-class drug resistance arises frequently in HIV-infected breastfeeding infants whose mothers initiate HAART postpartum. In: Program and abstracts of the 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, February 16-19, 2010:433. abstract.